Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children

Bibliography

• NO AUTHORS LISTED: Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). I Am. Acad. Child Adolesc. Psychiatry (2000) 39(2):182–193.
   PubMed Web of Science ®Google Scholar
• •This is an influential consensus statement from the US NIH.
   Google Scholar
• ROWLAND AS, UMBACH DM, STALLONE L, NAFTEL AJ, EM, SANDLER DP: Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am. J. Public Health (2002) 92(2):231–234.
   PubMed Web of Science ®Google Scholar
• SHARMA V, NEWCORN JH, MATIER-SHARMA K, HALPERIN JM: Attention-deficit and disruptive behavior disorders. In: Psychiatry Tasman A (Ed.), Harcourt Brace & Company, Philadelphia (1997):667–678.
   Google Scholar
• HOFFMAN BB: Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Goodman &- Gilman's The Pharmacological Basic of Therapeutics. Hardman JG, Limbird LE (Eds), McGraw-Hill, New York (2001).
   Google Scholar
• KEATING GM, FIGGITT DP: Dexmethylphenidate. Drugs (2002) 62(13):1899–1904. Discussion 1905–1908.
   Google Scholar
• BARKLEY RA, FISCHER M, SMALLISH L, FLETCHER K: Does the treatment of attention-deficit/ hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics (2003) 111(1):97–109.
   PubMed Web of Science ®Google Scholar
• CHARLES L, SCHAIN RJ, GUTHRIE D: Long-term use and discontinuation of methylphenidate with hyperactive children. Dev. Med. Child Neurol. (1979) 21(0758–764.
   PubMed Web of Science ®Google Scholar
• COLLIER CP, SOLDIN SJ, JM, MACLEOD SM, WEINBERG F, ROCHEFORT JG: Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity. Pharmacokinet. (1985) 10(3):269–278.
   Google Scholar
• GILLBERG C, MELANDER H, KNORRING AL et al:-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Gem Psychiatry(1997) 54(9):857–864.
   Google Scholar
• ••This is one of only a few prospectivelong-term studies of ADHD.
   Google Scholar
• NO AUTHORS LISTED: 14-month randomized clinical trial of treatment strategies for attention-deficit/ hyperactivity disorder. MTA Cooperative Group. Treatment Study of Children with ADHD. Arch. Gen. Psychiatry (1999) 56(12):1073–1086.
   Google Scholar
• ••A large-scale, long-term, randomisedprospective study of ADHD.
   Google Scholar
• WOLRAICH ML, GREENHILL LL, PELHAM W et al: Randomized, controlled trial of Oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics (2001) 108(4):883–892.
   PubMed Web of Science ®Google Scholar
• FINDLING RL, SHORT EJ, MANOS MJ: Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder. J Am. Acad. Child Adolesc. Psychiatry (2001) 40(12):1441–1447.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, LOPEZ FA, BOELLNER SW, CHANDLER MC: A randomized, double-blind, placebo-controlled, parallel-group study of 5LI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics (2002) 110(2 Pt 1):258–266.
   Google Scholar
• GREENHILL LL, FINDLING RL, SWANSON JM: A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics (2002) 109(3):E39.
   PubMed Web of Science ®Google Scholar
• LISSKA MC, RIVKEES SA: methylphenidate use slows the growth of children: a community based study. Endocrinol. Metab. (2003) 16(5):711–718.
   Google Scholar
• PLISZKA SR: The use of psychostimulants in the pediatric patient. Pediatr. Clin. North Am. (1998) 45(5):1085–1098.
   PubMed Web of Science ®Google Scholar
• KLEIN RG, MANNUZZA S: Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Arch. Gen. Psychiatry (1988) 45(12):1131–1134.
   PubMed Web of Science ®Google Scholar
• PIZZI WJ, RODE EC, BARNHART JE: Differential effects of methylphenidate on the growth of neonatal and adolescent rats. Neurotoxicol. Teratol. (1987) 9(2):107–111.
   PubMed Web of Science ®Google Scholar
• SPENCER T, BIEDERMAN J, WILENS T: Growth deficits in children with attention deficit hyperactivity disorder. (1998) 102(2 Pt 3):501–506.
   Google Scholar
• •Provides important data regarding the relationship between stimulant treatment and effects on growth.
   Google Scholar
• GAD OW KD, SVERD J, SPRAFKIN J, EE, EZOR SN: Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch. Gen. Psychiatry (1995) 52(6):444–455.
   PubMed Web of Science ®Google Scholar
• •Provides important safety and efficacy data regarding the use of MPH in the treatment of children with tic disorder.
   Google Scholar
• CASTELLANOS FX, GIEDD JN, ELIA J et al.: Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. Am. Acad. Child Adolesc. Psychiatry (1997) 36(5):589–596.
   Google Scholar
• EFRON D, JARMAN F, BARKER M: Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics (1997) 100(4):662–666.
   PubMed Web of Science ®Google Scholar
• THE TOURETTE'S SYNDROME STUDY GROUP: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology (2002) 58(4):527–536.
   Google Scholar
• LIEPMAN MR, KELLER DM, BOTELHO RJ, MONROE AD, SLOANE MA: Understanding and preventing substance abuse by adolescents: a guide for primary care clinicians. Prim. Care (1998) 25(1):137–162.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, WILENS T, MICK E, SPENCER T, FARAONE SV: Pharmacotherapy of attention-deficit/ hyperactivity disorder reduces risk for substance use disorder. Pediatrics (1999) 104(2):e20.
   PubMed Web of Science ®Google Scholar
• MANNUZZA S, KLEIN RG, JL III: stimulant treatment place children at risk for adult substance abuse? controlled, prospective follow up study. Child Adolesc. Psychopharmacol (2003) 13(3):273–282.
   PubMed Web of Science ®Google Scholar
• WILENS TE, FARONE SV, J, GUNAWARDENE S: Does stimulant therapy of attention-deficit/ hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics (2003) 111(1):179–185.
   PubMed Web of Science ®Google Scholar
• ••Provides an excellent summary of the datathat has examined the relationships with psychostirnulant treatment for ADHD and subsequent development of abuse.
   Google Scholar
• GREENBERG LM, YELLIN AM: Blood pressure and pulse changes in hyperactive children treated with imipramine and methylphenidate. Am. j Psychiatry (1975) 132(12):1325–1326.
   PubMed Web of Science ®Google Scholar
• BENNETT FC, BROWN RT, CRAVER J, ANDERSON D: Stimulant medication for the child with attention-deficit/hyperactivity disorder. Pediatr. Clin. North Am. (1999) 46(5):929–944, vii.
   Google Scholar
• FINDLING RL, SHORT EJ, MANOS MJ: Short-term cardiovascular effects of methylphenidate and adderall. I. Am. Acad. Child Adolesc. Psychiatry (2001) 40(5):525–529.
   PubMed Web of Science ®Google Scholar
• JAMES RS, SHARP WS, BASTAIN TM et al.: Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40(11):1268–1276.
   PubMed Web of Science ®Google Scholar
• EFRON D, JARMAN F, BARKER M: Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics (1997) 100(6):E6.
   PubMed Web of Science ®Google Scholar
• MAROTTA PJ, ROBERTS EA: Pemoline hepatotoxicity in children. Pediatr. (1998) 132(5):894–897.
   Web of Science ®Google Scholar
• BERKOVITCH M, POPE E, PHILLIPS J, KOREN G: Pemoline-associated fulminant liver failure: testing the evidence for causation. Clin. Pharmacol Ther: (1995) 57(6):696–698.
   PubMed Web of Science ®Google Scholar
• STERLING MJ, KANE M, GRACE ND: Pemoline-induced autoimmune hepatitis. Gastroenterol (1996) 91(10):2233–2234.
   Web of Science ®Google Scholar
• HOCHMAN JA, WOODARD SA, COHEN MB: Exacerbation of autoimmune hepatitis: another hepatotoxic effect of pemoline therapy. Pediatrics (1998) 101(1 Pt 1):106–108.
   Google Scholar
• NEHRA A, MULLICK F, ISHAK KG, ZIMMERMAN HJ: Pemoline-associated hepatic injury. Gastroenterology (1990) 99(5):1517–1519.
   PubMed Web of Science ®Google Scholar
• JAFFE SL: Pemoline and liver function. Am. Acad. Child Adolesc. Psychiatry (1989) 28(3):457–458.
   PubMed Web of Science ®Google Scholar
• JENSEN P: Longer term effects of stimulant treatments for attention-deficit/hyperactivity disorder. J. Atten. Disord. (2002) 6\(Suppl. 1):545–556.
   Google Scholar
• RAPPORT MD, MOFFITT C: deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects. Clin. Psycho]. Rev (2002) 22(8):1107–1131.
   PubMed Web of Science ®Google Scholar
• SCHACHAR R, JADAD AR, GAULD M et al.: Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies. Can. I Psychiatry (2002) 47(4)337–348.
   Google Scholar
• WILENS TE, BIEDERMAN J, SPENCER TJ: Attention deficit/ hyperactivity disorder across the lifespan. Annu. Rev Med. (2002) 53:113–131.
   PubMed Web of Science ®Google Scholar
• QUINN PO, RAPOPORT JL:-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am. Psychiatry (1975) 132(3):241–245.
   PubMed Web of Science ®Google Scholar
• KLEIN RG, LANDA B, MATTES JA, KLEIN DF: Methylphenidate and growth in hyperactive children. A controlled withdrawal study. Arch. Gen. Psychiatry (1988) 45(12):127–130.
   Google Scholar
• SPENCER TJ, BIEDERMAN J, HARDING M, O'DONNELL D, FARAONE SV, WILENS TE: Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? j Am. Acad. Child Adolesc. Psychiatry (1996) 35(11):1460–1469.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, FARAONE SV, MONUTEAUX MC, PLUNKETT EA, GIFFORD J, SPENCER T: Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics (2003) 111(5 Pt 1):1010–1016.
   Google Scholar
• •Describes evidence that ADHD treatment is not associated with growth retardation in girls.
   Google Scholar
• WILENS T, PELHAM W, STEIN M et al: treatment with once-daily methylphenidate: interim 12-month results from a long-term open-label study. J. Am. Acad. Child Adolesc. Psychiatry (2003) 42(4):424–433.
   PubMed Web of Science ®Google Scholar